Results 231 to 240 of about 19,420 (250)
Some of the next articles are maybe not open access.
Oral Varenicline for Smoking Cessation
Annals of Pharmacotherapy, 2007Objective: To review the pharmacology, pharmacokinetics, efficacy, and safety of varenicline and provide a review of relevant clinical data. Data Sources: A MEDLINE search (2001–December 2006) was conducted using the key words varenicline and nicotine replacement therapy for clinical trials limited to human subjects and published in English.
Jeffrey A Kyle, Seena Zierler-Brown
openaire +2 more sources
Varenicline for Youth Nicotine Vaping Cessation: A Randomized Clinical Trial.
Journal of the American Medical Association (JAMA)Importance Electronic cigarette use (vaping) among adolescents and young adults is common. Few treatments have been tested in this population. Objective To evaluate the efficacy of varenicline for nicotine vaping cessation in youth who do not smoke ...
A. E. Evins +14 more
semanticscholar +1 more source
Adynamic Ileus Induced by Varenicline
Current Drug Safety, 2011Varenicline is a drug specifically developed for smoking cessation. Gastrointestinal symptoms are among the most common side effects (nausea, vomiting, and constipation). Here, we described the case of a 75 year-old man who suffered from functional adynamic ileus while taking varenicline. Adynamic ileus is a rare condition on treatment with varenicline.
Angel Ruedas López, Pablo Guisado Vasco
openaire +3 more sources
Exacerbation of Schizophrenia by Varenicline
American Journal of Psychiatry, 2007A 42-year-old woman with schizophrenia had been treated for 17 years with 1015 mg of thiothixene. She had several brief psychotic episodes per year, which seldom lasted for more than 3 days. She had no overt psychotic symptoms during an office visit one month previously.
openaire +2 more sources
Journal of Clinical Psychiatry, 2020
OBJECTIVE Varenicline has been shown to be safe and effective in improving abstinence in smokers. However, results from randomized, placebo-controlled trials using varenicline for alcohol use disorders (AUDs) are inconsistent.
Kriti Gandhi +5 more
semanticscholar +1 more source
OBJECTIVE Varenicline has been shown to be safe and effective in improving abstinence in smokers. However, results from randomized, placebo-controlled trials using varenicline for alcohol use disorders (AUDs) are inconsistent.
Kriti Gandhi +5 more
semanticscholar +1 more source
An efficient synthesis of varenicline
Tetrahedron Letters, 2010Synthesis of varenicline the antismoking drug has been achieved in six steps with 10% overall yield. A Diels–Alder reaction, oxidative cleavage of an olefin and reductive amination remain as key steps in the ...
Srinivas Pasikanti +6 more
openaire +2 more sources
Chantix (Varenicline Tartrate)
Journal of Addictions Nursing, 2009Chantix is one of the newer pharmaceutical agents for nicotine dependency. Chantix is manufactured by Pfizer Labs.Nicotinic receptors are present in the brain.
openaire +2 more sources
Mental health effects of varenicline [PDF]
BMJ, 2015 Results from a new meta-analysis seem at odds with patients’ real life experiences The safety of drugs for smoking cessation, in particular varenicline (Chantix, Champix; Pfizer) and its effects on mental health, has been debated by regulatory authorities, researchers, prescribers, and patients since varenicline was first marketed nine years ago.
openaire +2 more sources
Acute Worsening of Tics on Varenicline
Clinical Neuropharmacology, 2017Objective The aim of this study was to report worsening of Tourette syndrome (TS) in 2 patients treated with varenicline. Background Abnormal dopaminergic signaling is likely involved in the pathophysiology of TS.
Anhar Hassan +4 more
openaire +3 more sources